Tris Pharma's Onyda XR (clonidine hydrochloride), the first liquid, non-stimulant medication for ADHD, is now available in the U.S. for pediatric patients aged 6 and older.
Tris Pharma's cebranopadol significantly reduced pain intensity in patients following abdominoplasty in the ALLEVIATE-1 Phase 3 trial.